列沃素诱导的肝毒性在患有军团病的患者:影响和管理
Mohamed Ismail1, Nishi Parikh2, Merry Zhai2
1Medicine, Rutgers University New Jersey Medical School, Newark, USA.
Cureus
|January 29, 2024
概括
使用勒沃素治疗军团病可能会导致肝损伤. 这份病例报告强调了勒沃素诱导的肝毒性风险在患有军团病的患者中.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 军团病 (LD) 是一种由军团菌细菌引起的严重肺炎.
- 利沃素是一种诺基诺隆抗生素,由于其广泛的疗效,它是常见的LD治疗方法.
- 肝毒性是一种潜在的,尽管很少见的,levofloxacin的不良影响.
研究的目的:
- 在患有军团病的患者中调查levofloxacin使用和肝毒性之间的关联.
- 在LD治疗的背景下,讨论levofloxacin诱导的肝损伤的临床影响.
主要方法:
- 病例报告详细介绍了一名被诊断患有军团士兵病的患者.
- 对临床表现,治疗过程和实验室发现的审查.
- 分析levofloxacin管理与肝毒性开始之间的时间关系.
主要成果:
- 患者患有肝酶升高,与药物诱导的肝损伤相一致,在为LD治疗levofloxacin后进行治疗.
- 肝毒性在停止使用勒沃富洛克萨后消失.
结论:
- 利沃素虽然对军团病有效,但具有肝毒性风险.
- 临床医生应监测肝功能,在患者治疗勒沃素的LD.
- 在患有先前存在的肝病或发生肝毒性的患者中,可以考虑使用替代抗生素策略.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
120
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
120
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pleural Effusion II: Symptoms and Management
176
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
176
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K


